Mitchell Kapoor Analyst Performance

Biotech Analyst at HC Wainwright

Mitchell Kapoor is a stock analyst at HC Wainwright in the medical sector, covering 27 publicly traded companies. Over the past year, Mitchell Kapoor has issued 66 stock ratings, including buy and hold recommendations. While full access to Mitchell Kapoor's proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Mitchell Kapoor's coverage history, rating activity, and performance tendencies — helping individual investors make more informed trading decisions.

Analyst Ranking: Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating MarketBeat
Average Return: 00.00% 12-Month ROI
Success Rate: 00.00% Profitable Ratings
Total Ratings: 66 Last 0 Years
Buy Recommendations: 87.88% 58 Buy Ratings
Companies Covered: 27 Unique Companies

Ratings Distribution

Rating	Percentage	Count
Strong Buy	0.0%	0 ratings
Buy	87.9%	58 ratings
Hold	12.1%	8 ratings
Sell	0.0%	0 ratings

Out of 66 total stock ratings issued by Mitchell Kapoor at HC Wainwright, the majority (87.9%) have been Buy recommendations, followed by 12.1% Hold.

Best & Worst Calls

This analyst does not have any ratings with enough history to determine best and worst calls.

Exchange Coverage

Exchange	Percentage	Count
NASDAQ	100.0% of companies on NASDAQ	27 companies

Mitchell Kapoor, an analyst at HC Wainwright, currently covers 27 companies listed on , with the majority traded on NASDAQ.

Coverage Focus

Sector Icon	Sector	Percentage
	Medical 27 companies	100.0%

Mitchell Kapoor of HC Wainwright specializes in stock coverage within the Medical sector.

Coverage Industries

Industry	Percentage
MED - BIOMED/GENE 17 companies	63.0%
MED - DRUGS 10 companies	37.0%

Timeframe

Start Date

End Date

Rating

12-Month ROIAll ROI

Export to Excel

Company	Report Date	Action	Report Date Price	12-Month Price Target	Rating
CRSP CRISPR Therapeutics	8/7/2025	Boost Price Target	$56.34	$80.00	Buy
HALO Halozyme Therapeutics	8/6/2025	Boost Price Target	$60.81	$75.00	Buy
IONS Ionis Pharmaceuticals	7/31/2025	Reiterated Rating	$43.37	$65.00	Buy
ALMS Alumis	7/25/2025	Reiterated Rating	$3.86	$14.00	Buy
KRRO Korro Bio	7/24/2025	Reiterated Rating	$16.85	$100.00	Buy
ORKA Oruka Therapeutics	7/23/2025	Reiterated Rating	$14.06	$45.00	Buy
LEGN Legend Biotech	7/17/2025	Reiterated Rating	$39.75	$75.00	Buy
LEGN Legend Biotech	7/8/2025	Reiterated Rating	$35.87	$75.00	Buy
TYRA Tyra Biosciences	7/1/2025	Reiterated Rating	$9.57	$30.00	Buy
SMMT Summit Therapeutics	7/1/2025	Reiterated Rating	$21.28	$44.00	Buy

LYEL Lyell Immunopharma	6/24/2025	Reiterated Rating	$8.99	$10.00	Neutral
VERV Verve Therapeutics	6/18/2025	Downgrade	$11.38	$13.50	Neutral
TIL Instil Bio	6/5/2025	Reiterated Rating	$34.40	$125.00	Buy
BOLD Boundless Bio	6/2/2025	Initiated Coverage	$1.10	$5.00	Buy
AVTX Avalo Therapeutics	6/2/2025	Upgrade	$3.95	$15.00	Buy
HALO Halozyme Therapeutics	5/29/2025	Reiterated Rating	$54.43	$72.00	Buy
KYTX Kyverna Therapeutics	5/27/2025	Upgrade	$2.27	$5.00	Buy
TIL Instil Bio	5/22/2025	Lower Price Target	$16.22	$105.00	Buy
LXEO Lexeo Therapeutics	5/16/2025	Lower Price Target	$2.70	$15.00	Buy
CTMX CytomX Therapeutics	5/15/2025	Upgrade	$2.38	$5.00	Buy
NGNE Neurogene	5/13/2025	Lower Price Target	$17.70	$45.00	Buy
KRRO Korro Bio	5/8/2025	Lower Price Target	$13.84	$100.00	Buy
ALMS Alumis	4/30/2025	Reiterated Rating	$4.33	$14.00	Buy
EDIT Editas Medicine	4/28/2025	Initiated Coverage	$1.54	$3.00	Buy
HALO Halozyme Therapeutics	4/25/2025	Reiterated Rating	$59.25	$72.00	Buy
LEGN Legend Biotech	4/16/2025	Reiterated Rating	$33.74	$75.00	Buy
LYEL Lyell Immunopharma	4/16/2025	Reiterated Rating	$9.18	$20.00	Neutral
VERV Verve Therapeutics	4/14/2025	Boost Price Target	$4.05	$25.00	Buy
RNAC Cartesian Therapeutics	4/9/2025	Reiterated Rating	$9.52	$40.00	Buy
RLYB Rallybio	4/9/2025	Reiterated Rating	$0.25		Neutral
LXEO Lexeo Therapeutics	4/8/2025	Reiterated Rating	$1.79	$23.00	Buy
LEGN Legend Biotech	4/8/2025	Reiterated Rating	$30.25	$75.00	Buy
IONS Ionis Pharmaceuticals	4/7/2025	Initiated Coverage	$27.09	$45.00	Buy
KYTX Kyverna Therapeutics	4/3/2025	Lower Price Target	$2.15	$4.00	Neutral
MGX Metagenomi	4/3/2025	Lower Price Target	$1.33	$7.00	Buy
ZURA Zura Bio	4/3/2025	Lower Price Target	$1.17	$3.00	Neutral
IPSC Century Therapeutics	4/3/2025	Lower Price Target	$0.47	$2.00	Buy
RANI Rani Therapeutics	4/3/2025	Reiterated Rating	$1.39	$9.00	Buy
TYRA Tyra Biosciences	3/31/2025	Reiterated Rating	$9.77	$30.00	Buy
LXEO Lexeo Therapeutics	3/26/2025	Reiterated Rating	$4.44	$23.00	Buy

NGNE Neurogene	3/25/2025	Lower Price Target	$13.96	$50.00	Buy
VERV Verve Therapeutics	3/25/2025	Reiterated Rating	$5.78	$15.00	Buy
ABEO Abeona Therapeutics	3/24/2025	Reiterated Rating	$5.15	$15.00	Buy
KRRO Korro Bio	3/20/2025	Reiterated Rating	$23.72	$115.00	Buy
RLYB Rallybio	3/17/2025	Reiterated Rating	$0.63	$5.00	Buy
RNAC Cartesian Therapeutics	3/14/2025	Lower Price Target	$16.61	$40.00	Buy
LYEL Lyell Immunopharma	3/13/2025	Reiterated Rating	$13.43	$20.00	Neutral
LEGN Legend Biotech	3/12/2025	Boost Price Target	$37.19	$75.00	Buy
CTMX CytomX Therapeutics	3/7/2025	Reiterated Rating	$0.62		Neutral
HALO Halozyme Therapeutics	3/6/2025	Reiterated Rating	$59.53		Buy
NTLA Intellia Therapeutics	3/5/2025	Initiated Coverage	$9.10	$30.00	Buy
TIL Instil Bio	3/5/2025	Reiterated Rating	$17.50	$110.00	Buy
VERV Verve Therapeutics	2/28/2025	Boost Price Target	$6.20	$15.00	Buy
SMMT Summit Therapeutics	2/25/2025	Reiterated Rating	$18.84	$44.00	Buy
ABEO Abeona Therapeutics	2/19/2025	Reiterated Rating	$5.85	$15.00	Buy
HALO Halozyme Therapeutics	2/19/2025	Boost Price Target	$57.90	$72.00	Buy
TYRA Tyra Biosciences	2/18/2025	Reiterated Rating	$13.19	$30.00	Buy
RLYB Rallybio	2/12/2025	Reiterated Rating	$0.75	$5.00	Buy
HALO Halozyme Therapeutics	2/4/2025	Reiterated Rating	$56.28	$70.00	Buy
CRSP CRISPR Therapeutics	2/3/2025	Initiated Coverage	$41.59	$65.00	Buy
RNAC Cartesian Therapeutics	1/28/2025	Reiterated Rating	$19.42	$45.00	Buy
IPSC Century Therapeutics	1/22/2025	Reiterated Rating	$0.90	$5.00	Buy
LEGN Legend Biotech	1/21/2025	Reiterated Rating	$32.66	$73.00	Buy
RLYB Rallybio	1/13/2025	Reiterated Rating	$0.94	$5.00	Buy
TYRA Tyra Biosciences	1/13/2025	Reiterated Rating	$15.20	$30.00	Buy
HALO Halozyme Therapeutics	1/10/2025	Boost Price Target	$53.76	$70.00	Buy

Stock Forecasts and Research Tools

Today's Ratings

Top-Rated Stocks

More Ratings Tools

Price Forecasts for Popular Stocks

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.